Study of the Chemical Profile and Anti-Fungal Activity against Candida auris of Cinnamomum cassia Essential Oil and of Its Nano-Formulations Based on Polycaprolactone
- PMID: 36679069
- PMCID: PMC9860731
- DOI: 10.3390/plants12020358
Study of the Chemical Profile and Anti-Fungal Activity against Candida auris of Cinnamomum cassia Essential Oil and of Its Nano-Formulations Based on Polycaprolactone
Abstract
Background: Candida auris represents an emerging pathogen that results in nosocomial infections and is considered a serious global health problem. The aim of this work was to evaluate the in vitro antifungal efficacy of Cinnamomum cassia essential oil (CC-EO) pure or formulated in polycaprolactone (PCL) nanoparticles against ten clinical strains of C. auris.
Methods: nanoparticles of PCL were produced using CC-EO (nano-CC-EO) and cinnamaldehyde (CIN) through the nanoprecipitation method. The chemical profile of both CC-EO and nano-CC-EO was evaluated using SPME sampling followed by GC-MS analysis. Micro-broth dilution tests were performed to evaluate both fungistatic and fungicidal effectiveness of CC-EO and CIN, pure and nano-formulated. Furthermore, checkerboard tests to evaluate the synergistic action of CC-EO or nano-CC-EO with micafungin or fluconazole were conducted. Finally, the biofilm disrupting activity of both formulations was evaluated.
Results: GC-MS analysis shows a different composition between CC-EO and nano-CC-EO. Moreover, the microbiological analyses do not show any variation in antifungal effectiveness either towards the planktonic form (MICCC-EO = 0.01 ± 0.01 and MICnano-CC-EO = 0.02 ± 0.01) or the biofilm form. No synergistic activity with the antifungal drugs tested was found.
Conclusions: both CC-EO and nano-CC-EO show the same antimicrobial effectiveness and are potential assets in the fight against C. auris.
Keywords: antifungal properties; cinnamaldehyde; cinnamon.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Ministero della Salute . Candida auris in Ambito Sanitario–Rapid Risk Assessment. Ministero della Salute; Rome, Italy: 2020.
-
- Ministero della Salute . Aggiornamento Delle Raccomandazioni per Il Controllo Dell’infezione Da Candida auris in Italia. Ministero della Salute; Rome, Italy: 2020.
-
- Ministero della Salute . Aggiornamento Delle Raccomandazioni per Il Controllo Dell’infezione Da Candida auris in Italia. Ministero della Salute; Rome, Italy: 2021.
LinkOut - more resources
Full Text Sources
Miscellaneous
